Cyanotic heart defect
Today we want to delve into the fascinating world of Cyanotic heart defect. Whether we are talking about history, science, technology, art or any other field, Cyanotic heart defect plays a fundamental role in our understanding of the world around us. From its origin to its current evolution, Cyanotic heart defect has been the subject of study and debate, generating great interest and impact on different aspects of society. Throughout this article, we will explore the different aspects and perspectives related to Cyanotic heart defect, with the aim of offering a comprehensive and comprehensive view on this relevant and intriguing topic.
| Cyanotic heart defect | |
|---|---|
| Other names | Right-to-left circulatory shunt |
| Specialty | Diagnosis |
A cyanotic heart defect is any congenital heart defect (CHD) that occurs due to deoxygenated blood bypassing the lungs and entering the systemic circulation, or a mixture of oxygenated and unoxygenated blood entering the systemic circulation. It is caused by structural defects of the heart such as right-to-left or bidirectional shunting, malposition of the great arteries, or any condition which increases pulmonary vascular resistance. The result may be the development of collateral circulation.
Types
- Tetralogy of Fallot (ToF)
- Total anomalous pulmonary venous connection
- Hypoplastic left heart syndrome (HLHS)
- Transposition of the great arteries (d-TGA)
- Truncus arteriosus (Persistent)
- Tricuspid atresia
- Interrupted aortic arch
- Pulmonary atresia (PA)
- Pulmonary stenosis (critical)
- Eisenmenger syndrome (reversal of shunt due to pulmonary hypertension).
Signs and symptoms
Presentation includes the following:[citation needed]
- Clubbing
- The patient assuming a crouching position
- Cyanosis - bluish face, particularly the lips; and bluish fingers and toes
- Crying
- Crabbiness/irritability
- Tachycardia
- Tachypnea
- A history of inadequate feeding
- Unusually large toe and fingernails
- Delayed development (both biological and physiological)
Diagnosis
 | This section is empty. You can help by adding to it. (October 2021) |
Management
- Morphine during Tet spells to decrease associated infundibular spasm.
- Prophylactic: Propranolol/Inderall
- Prostaglandin E (to keep the ductus arteriosus patent)
- Prophylactic antibiotic to prevent endocarditis
- Surgery: Variable. Superior Cavopulmonary Bypass (Bidirectional Glenn or Hemi-Fontan Procedure), Total Cavopulmonary Bypass (Fontan Completion Procedure). The purpose of these operations is to redirect the blood flow of the deoxygenated blood to the lungs by attaching the Vena Cava directly to the Pulmonary Artery causing the blood that flows into the lungs to be oxygenated before entering the chambers on the right side of the heart. Mathematical models are used to address the issue of pressure level alterations of circulation after the procedures. The pulmonary pressure resistance in the cavopulmonary connection is increased, and these models permit clear analyses of the pressure increase allowing doctors to avoid possible venous circulation congestion.
See also
References
- ^ "Cyanotic heart disease: MedlinePlus Medical Encyclopedia". medlineplus.gov. Retrieved 27 May 2019.
- ^ Page Elizabeth D Agabegi; Agabegi, Steven S. (2008). Step-Up to Medicine (Step-Up Series). Hagerstwon, MD: Lippincott Williams & Wilkins. ISBN 978-0-7817-7153-5.